Citation: Z. Harel et al., ADOLESCENTS REASONS FOR AND EXPERIENCE AFTER DISCONTINUATION OF THE LONG-ACTING CONTRACEPTIVES DEPO-PROVERA AND NORPLANT, Journal of adolescent health, 19(2), 1996, pp. 118-123
Citation: Z. Harel et al., ADOLESCENTS REASONS FOR, AND EXPERIENCE AFTER, DISCONTINUATION OF THELONG-ACTING CONTRACEPTIVES DEPO-PROVERA(R) AND NORPLANT(R), Journal of adolescent health, 18(2), 1996, pp. 133-133
Citation: Z. Harel et al., DEPO-PROVERA IN ADOLESCENTS - EFFECTS OF EARLY 2ND INJECTION OR PRIORORAL CONTRACEPTION, Journal of adolescent health, 16(5), 1995, pp. 379-384
Citation: Z. Harel et al., DEPO-PROVERA IN ADOLESCENTS - EFFECTS OF EARLY 2ND INJECTION ON PRIORORAL CONTRACEPTION, Journal of adolescent health, 16(2), 1995, pp. 133-133
Citation: Sl. Rosenthal et al., EXPERIENCE WITH SIDE-EFFECTS AND HEALTH RISKS ASSOCIATED WITH NORPLANT(R) IMPLANT USE IN ADOLESCENTS, Contraception, 52(5), 1995, pp. 283-285
Citation: Lm. Kollar et al., HEPATITIS-B VACCINE SERIES COMPLIANCE IN ADOLESCENTS, The Pediatric infectious disease journal, 13(11), 1994, pp. 1006-1008
Authors:
BIRO FM
REISING SF
DOUGHMAN JA
KOLLAR LM
ROSENTHAL SL
Citation: Fm. Biro et al., COMPARISON OF DIAGNOSTIC METHODS IN ADOLESCENT GIRLS WITH AND WITHOUTSYMPTOMS OF CHLAMYDIA UROGENITAL INFECTION, Pediatrics, 93(3), 1994, pp. 476-480